Immuneering Corp Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Immuneering Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2022 to Q1 2024.
  • Immuneering Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $980K, a 309% increase year-over-year.
  • Immuneering Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $28.4M, a 149558% increase from 2022.
  • Immuneering Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $19K, a 100% decline from 2021.
  • Immuneering Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $144M, a 280% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $980K +$741K +309% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $239K +$46.3K +24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $193K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.